-
Synthetic Stimulants
Novel Psychoactive Substances (NPS) are a diverse group of synthetic substances created to mimic the effects of scheduled or illicit drugs; however, they…
-
Nitazene Analogs
Nitazene analogs are a subclass of designer opioids that are structurally different from opioids but attach to the same mu-opioid receptor.1 This Novel…
-
Designer Benzodiazepines
Designer benzodiazepines (DZBDs) represent a major public health issue and their prevalence has increased substantially over the last decade.1 Slight alterations…
-
What Did My Patient Actually Take? An Overview of Alcohol Results
According to the National Survey on Drug Use and Health conducted in 2015, 86.4% of people over the age of 18 reported drinking alcohol at some point in…
-
Synthetic Cannabinoids
Novel Psychoactive Substances (NPS) are a diverse group of synthetic substances created to mimic the effects of prescription or illicit drugs that are…
-
Polysubstance Use: Fentanyl and Stimulants
The United States is in an overdose epidemic, with the CDC estimating that 106,699 individuals died of a drug-involved overdose in 2021 alone. Most deaths…
-
Spotlight on Potential Interactions Involving Behavioral Health & Substance Use Disorder Medications
Drug-drug and drug-food interactions (DDIs) contribute to adverse drug events (ADEs) which can range in severity from mild effects to life-threatening.…